PERU RAMIRO G

SEC Form 4 insider trading activity

PERU RAMIRO G has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including ELV, SM, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 17, 2026.

On the most recent filing, PERU RAMIRO G is listed as Director at Elevance Health, Inc. Inside the rolling window, PERU RAMIRO G reported 1 open-market purchase totaling $366K in ELV and 1 open-market sale totaling $834K in SM. The largest disclosed transaction in the window is a sale of 24,553 SM shares on May 21, 2026, worth $834K.

Companies traded

Other insiders at ELV

Insider Buying

$366K

reported purchases (SEC code P)

Insider Selling

$834K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
ELV
PERU RAMIRO G
Purchase$366KJul 17SEC ↗
SM
PERU RAMIRO G
Sale$834KMay 22SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has PERU RAMIRO G made?

PERU RAMIRO G has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including ELV, SM since 2026.

Which companies does PERU RAMIRO G trade?

PERU RAMIRO G has filed SEC Form 4 disclosures for 2 companies, including ELV, SM.

When was PERU RAMIRO G's most recent SEC Form 4 filing?

PERU RAMIRO G's most recent SEC Form 4 filing on Tracefour is dated Jul 17, 2026.

What is PERU RAMIRO G's total buy and sell value in the current window?

Inside the rolling retention window, PERU RAMIRO G bought $366K and sold $834K based on SEC Form 4 filings.

What was PERU RAMIRO G's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 24,553 SM shares on 2026-05-21, worth $834K, per SEC Form 4 filings.